First SICAF Anchors Più Medical’s IPO with €4.8 Million Investment
First SICAF, part of First Capital S.p.A., invests €4.8 million in Più Medical's IPO on Euronext Growth Milan, supporting its growth with a board appointment and a 12-month lock-up. This strategic move reflects confidence in Più Medical's market positioning. First Capital specializes in Private Investments in Public Equity, focusing on small and medium-sized companies. Analyst rating for First Capital is a Buy with a EUR30.40 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
The latest announcement is out from First Capital S.p.A. ( (IT:FIC) ).
First SICAF, a vehicle of First Capital S.p.A., has invested 4.8 million euros as an anchor investor in Più Medical S.p.A., a leading group in the Italian pharmacy sector, as part of its IPO on Euronext Growth Milan. This strategic investment aims to support Più Medical’s growth and includes a board appointment and a 12-month lock-up commitment, highlighting First SICAF’s confidence in Più Medical’s expansion plans and market positioning.
The most recent analyst rating on (IT:FIC) stock is a Buy with a EUR30.40 price target. To see the full list of analyst forecasts on First Capital S.p.A. stock, see the IT:FIC Stock Forecast page.
More about First Capital S.p.A.
First Capital S.p.A. is a financial holding company specializing in Private Investments in Public Equity and Private Equity investments, focusing on small and medium-sized listed companies, particularly those in the pre-IPO phase or interested in future listings. The company employs an active investment management approach, often seeking roles in the boards or control bodies of target companies to enhance long-term value.
Average Trading Volume: 2,610
Technical Sentiment Signal: Buy
Current Market Cap: €66.28M
Find detailed analytics on FIC stock on TipRanks’ Stock Analysis page.
